Fundz

Mapmygenome acquires dnaPower Inc. for expansion

PRIVATEOct 21, 2026

Acquiring Company

Mapmygenome

Acquired Company

dnaPower

HyderabadVancouverHealth CareBiotechnologyHealth CareFitnessNutrition

Description

Mapmygenome has completed the acquisition of dnaPower Inc. This strategic move expands Mapmygenome's North American operations and creates a centralized platform for DNA and microbiome testing. The integration aims to enhance proactive healthcare capabilities across Canada and the US.

Who to call at Mapmygenome, and when

When Mapmygenome changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Mapmygenome raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mapmygenome, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mapmygenome

Location

Hyderabad, Telangana, India

About

Mapmygenome is an AI-driven leader in genomics and personalized health. The company leverages advanced genomic and microbiome testing for personalized health solutions. Founded a decade ago, it conducts high-accuracy diagnostic genomic tests in a CAP-accredited lab. Their offerings include at-home DNA tests aimed at proactive health and longevity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mapmygenome makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Anuradha
Likely contact at this company
••••••••@••••••••

See Anuradha's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mapmygenome's next move

Learn about Strategic plan

Frequently asked

Who acquired dnaPower?

dnaPower was acquired by Mapmygenome, based in Hyderabad. The deal was reported on October 21, 2026. Mapmygenome is an AI-driven leader in genomics and personalized health. The company leverages advanced genomic and microbiome testing for personalized health solutions. Mapmygenome is privately held and operates in Health Care.

When did Mapmygenome acquire dnaPower?

Mapmygenome's acquisition of dnaPower was reported on October 21, 2026. Mapmygenome has completed the acquisition of dnaPower Inc. This strategic move expands Mapmygenome's North American operations and creates a centralized platform for DNA and microbiome testing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does dnaPower do?

dnaPower specializes in actionable DNA-based health, nutrition, fitness, methylation, and longevity insights for consumers and practitioners. Founded in 2008, the company is a pioneer in personal genomics. It is privately held, operating in Biotechnology, and is based in Vancouver.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.